Drug distributors Cardinal Health Inc., McKesson Corp. and JM Smith Corp. on Wednesday prevailed at trial in Georgia in a case brought by families of opioid addicts accusing the companies of acting as drug dealers. A jury in Glynn County …
Drug distributors Cardinal Health Inc., McKesson Corp. and JM Smith Corp. on Wednesday prevailed at trial in Georgia in a case brought by families of opioid addicts accusing the companies of acting as drug dealers. A jury in Glynn County …
Drugmaker Endo International Plc on Thursday said it has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and marketing of opioids. Endo said the settlement includes …
At least six U.S. states, including Georgia, have decided they will not fully sign on to a proposed $26 billion settlement with three drug distributors and Johnson & Johnson, which have been accused of fueling the nation’s opioid epidemic, according …
NEW YORK, July 20 (Reuters) – The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid …
Consulting firm McKinsey & Co has agreed to pay at least $573 million to resolve claims by 40-plus U.S. states related to its role in the opioid epidemic and advice it gave to OxyContin maker Purdue Pharma, according to a …
Johnson & Johnson on Tuesday said it will contribute up to $1 billion more to a potential settlement of lawsuits alleging it and other companies fueled the U.S. opioid epidemic, bringing the total amount it would pay to $5 billion. …
The three largest U.S. drug distributors and a major generic-drug manufacturer have agreed to pay $260 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Drug distributors McKesson Corp., Cardinal Health Inc. …
The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether trial set to start next month, rejecting a request by drug distributors and pharmacies who say he is biased against …
Monday’s $572 million judgment against Johnson & Johnson may mean one analyst’s “bear case scenario” of $150 billion in opioid damages just got one step closer. Patrick Trucchio, a Berenberg analyst, on Tuesday renewed his April projection for U.S. liabilities …